BioSpace News Archive

EVERSANA , a leading provider of commercial services to the global life sciences industry, today announced it has selected Adobe Firefly for Enterprise to transform its content supply chains with the power of generative AI.

OneOncology, the fastest-growing national platform for independent oncology practices, has appointed Ian Flinn , MD, PhD, as Chief Scientific Officer.

Reviva Pharmaceuticals Holdings, Inc. announced that it has closed its previously announced registered direct offering with several healthcare-focused institutional investors.

NightHawk Biosciences, a fully integrated biopharmaceutical company specializing in the end-to-end development, manufacturing, and commercialization of innovative therapies, provided strategic, financial, and operational updates for the quarter ended September 30, 2023.

Elevai Labs, Inc., a medical aesthetic company specializing in physician-dispensed skincare, today announced the pricing of its initial public offering.

Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today announced the acceptance of seven abstracts for presentation at the upcoming American Epilepsy Society (AES) 2023 Annual Meeting, taking place in Orlando, Florida December 1-5, 2023.

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs with an emphasis on treatments for viral infections, today reported financial results for its fiscal fourth quarter and year ended September 30, 2023.

Edesa Biotech, Inc. (NASDAQ:EDSA) today announced favorable final results from a Phase 2b dose-ranging clinical study of the company’s drug candidate, EB01 (daniluromer), as a monotherapy for moderate-to-severe chronic Allergic Contact Dermatitis (ACD).

Bruker Corporation announced that its Board of Directors has approved payment of a quarterly cash dividend in the amount of $0.05 per share on the Company’s common stock.

Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO and Dan Dischner, S.V.P. of Corporate Communications, will participate in an Analyst-Moderated fireside chat at the Piper Sandler 35th Annual Healthcare Conference on Wednesday, November 29, 2023 at 9:30 am EST.